Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
GOLIMUMAB 50MG/4ML (LOCAL 3507016) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved June 30, 2026 , from http://ppman.hank.ai/transparency/procedure/3507016/by-state?code_type=LOCAL
“GOLIMUMAB 50MG/4ML (LOCAL 3507016) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/3507016/by-state?code_type=LOCAL. Accessed
June 30, 2026 .
“GOLIMUMAB 50MG/4ML (LOCAL 3507016) by State,” HANK Price Transparency ,
accessed June 30, 2026 ,
http://ppman.hank.ai/transparency/procedure/3507016/by-state?code_type=LOCAL.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
LOCAL · across United States
3507016 — Golimumab 50mg/4ml
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$4,206
National median
$3,185 – $4,807
IQR (p25 – p75)
3
hospitals filing
1
states
Walking in without insurance?
Cash / self-pay price
Cash median
$4,807
vs. negotiated
+14.3%
Hospitals reporting
3
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 3507016 (LOCAL), with interquartile range
State Median p25 p75
TX $4,206 $3,185 $4,807